Impact of Ticagrelor vs. Clopidogrel in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention After Risk Stratification With the CHA(2)DS(2)-VASc Score

BACKGROUNDS: The clinical benefit of ticagrelor vs. clopidogrel in unselected patients with acute coronary syndrome (ACS) after percutaneous coronary intervention (PCI) remains controversial in the real world. This study was aimed to investigate the impact of ticagrelor vs. clopidogrel in subjects w...

Descripción completa

Detalles Bibliográficos
Autores principales: Na, Kun, Qiu, Miaohan, Ma, Sicong, Li, Yi, Li, Jing, Liu, Rong, Zhang, Jiaoyang, Han, Yaling
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9013766/
https://www.ncbi.nlm.nih.gov/pubmed/35445091
http://dx.doi.org/10.3389/fcvm.2022.808571

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9013766/
https://www.ncbi.nlm.nih.gov/pubmed/35445091
http://dx.doi.org/10.3389/fcvm.2022.808571

Ejemplares similares